Related Experiment Video
Updated: Jun 18, 2026
09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
20.7K
Immune Thrombocytopenia in Children
Lily Dolatshahi1, Amani Ashraf1
1SSM Health Cardinal Glennon Children's Hospital /Saint Louis University, St. Louis, Missouri.
Pediatrics in Review
|March 31, 2026
Summary
Immune thrombocytopenia (ITP) is a common bleeding disorder causing low platelets. Management focuses on symptom severity and quality of life, requiring expertise in autoimmune conditions.
Area of Science:
- Hematology
- Immunology
- Autoimmune Diseases
Background:
- Immune thrombocytopenia (ITP) is a prevalent acquired bleeding disorder.
- ITP is defined by thrombocytopenia (low platelet count) with normal hemoglobin and white blood cell counts.
- Classification of ITP depends on triggers and duration.
Purpose of the Study:
- To provide an overview of Immune thrombocytopenia (ITP).
- To highlight the diagnostic and management considerations for ITP.
- To emphasize the need for expertise in autoimmune disorders for ITP care.
Main Methods:
- Literature review on ITP pathophysiology, classification, and management.
- Synthesis of current understanding of ITP diagnosis.
- Analysis of treatment strategies based on symptom severity and quality of life.
Main Results:
- ITP management is guided by bleeding severity and impact on quality of life.
- Life-threatening bleeding necessitates aggressive treatment.
- Non-life-threatening symptoms affecting daily living also warrant therapeutic intervention.
Conclusions:
- Effective management of ITP requires a comprehensive understanding of its autoimmune basis.
- Expertise in the evolving field of autoimmune disorders is crucial for optimal ITP patient care.
- Diagnosis and treatment necessitate a nuanced approach considering individual patient factors.
Related Concept Videos
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...